Cbd/tch latest studies :

Latest studies about cbd /tch coming from Israel :

« Paediatrics

Two trials on spasticity in paediatrics patients suffering from cerebral palsy are in final stages, the first is a double blind, placebo control trial assessing safety and efficacy of Sativex® in 72 patients (NCT01898520, GW Research Ltd.), and the second is a randomized controlled trial comparing two cannabis oil formulations (5% CBD and 0.2% THC) and (5% CBD and 0.8% THC) provided by Tikun Olam Ltd in 40 patients (NCT02470325). In an intermediate analysis on 25 patients, adverse effects were rare and included worsening of seizures in 2 patients, behavioral changes in 2 and somnolence in 1 35. A large double blind, randomized, placebo‐controlled trial with crossover that is now recruiting, is assessing the safety, tolerability and efficacy of whole plant extract versus 99% CBD oil and placebo (provided by BOL pharma ltd) in 120 patients with autism spectrum disorder (NCT02956226). »

You can read about others conditions studed :


« While some of the public and mainstream media have already accepted medical cannabis to be effective in a lengthy list of conditions, clinical studies with an appropriate study design are few. Only few studies are prospective and most clinical trials investigating medical cannabis and its derivatives are not placebo controlled, not blinded and have small sample sizes. This situation leads to a division within the medical community: those in favor of using cannabis who also usually see themselves as pioneers in this area and tend to prescribe cannabis even when the evidence is insufficient, while opponents of medical cannabis might perhaps end up denying a patient cannabis even in situations where cannabis has been shown to be beneficial (pain, nausea and sleep disturbance, National Academies of Sciences Engineering and Medicine Report 38). Furthermore, rapidly developing clinical research is rather not focused, and many cannabis research programmes are concentrated around rare diseases, where the regulatory process and thus time to marketing are perceived to be shorter. Yet, we believe that cannabis derived medications should have a significant role in the treatment of chronic pain symptoms and to be a safer substitute for opioids in palliative care.

Israel has developed a regulatory environment where the indications for which cannabis can be prescribed are tightly regulated, and developed based on the accumulation of research and clinical experience data thus far. « 

No comments

Just for anybody’s who wants to comment on my blog : I am not confirming ANY comments on it I had too much spam messages and I don’t have time to see all comments which is good or spam … so I delate every day ALL COMMENTS send me

Sorry for your inconvenience but it’s like this

If you want to contact me ( not spam) send me mail:


And I will see if it’s really professional mail or just a spam ( haw to create my blog and not about nerologie – all spam I put in garbage !!!)

My blog is free I am not gaining money from it I don’t have time for useless comments.

Thanks for understanding

Book /Livre

Voilà mon livre « Marc L’invincible » est désormais en ligne et disponible* à l’achat dans la boutique Kindle: ( en français)


« Marc L’invincible: L’histoire vraie d’une récupération remarquable, après arrêt cardiaque et lésions cérébrales anoxiques », est désormais disponible en livre broché dans la boutique Amazon. Les lecteurs peuvent l’acheter:


Here is my book « Marc L’invincible » is now online and available * for purchase in the Kindle store: (in French)

I will do English translation ( just give me some time)

Ici lien vers page de Écrivain-biographe basée à Grenoble -Membre des Compagnons Biographes – Julie Lucquet qui à prêter son plume pour raconter notre histoire :


Cannabidiol (CBD) and mouvements disorders:

As a lot of parents with injured child I have heard about CBD and TCH oils…

so what I did: I found who is doing scientific studies about… I had a chance Israel is doing the most advanced studies about canabidols oils for CP and autisme.

So we met dr Blumkin only once for my son consultation in February 2017… before results of her study for cp was published…. my son was absolutely not candidate for Cannabidiol (CBD) oil. We have to consider Cannabidiol (CBD) and TCH as any other pharmaceutical Médecine so it can have side effects as any other medications… so for each case it must be taken in account for benefits/ possible side effects.

So hire contact if somebody needs it:

Lubov Blumkin MD

Head, Pediatric Movement Disorders Clinic

Pediatric Neurology Unit

Metabolic Neurogenetic Clinic

Wolfson Medical Center

Holon, Israel

Tel. +972-35028458


She did this study:

For cp

Hire Israel study published : « Medical cannabis in children with complex motor disorders »:





And as I know after she also was related for autism study for canabis in Israel… ( don’t have link)